Award to radha pharmaceuticals INC for atorvastatin calcium tablets for the base year with four one-year options.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79723D0025
- Awardee
-
Radha Pharmaceuticals Inc. UEI C1S5SQ88KY67
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- 6505--Atorvastatin Calcium Tablets Pre-Solicitation · 36E79723R0015 · Posted Apr 6, 2023
- Last date to order 77% complete
- IDV ceiling
- $72,305,203.55
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 9 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The VA National Acquisition Center awarded a single-award indefinite-delivery contract to Radha Pharmaceuticals Inc. for atorvastatin calcium tablets on October 1, 2023, with a ceiling value of $72,305,203.55. The award implements Executive Order 14398 on diversity, equity, and inclusion. Radha Pharmaceuticals is a minority-owned manufacturer and distributor of generic pharmaceuticals.
The contract carries a base year plus four one-year options, with ultimate completion on September 30, 2027. Work is performed to supply atorvastatin calcium tablets in various dosage strengths and package sizes to the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. Estimated annual requirements range from approximately 90 bottles for 10-milligram tablets to over 500,000 bottles for other dosages, with total estimated requirements exceeding 200,000 units annually across all strengths and configurations.
NAICS code 325412 applies (Pharmaceutical Preparation Manufacturing). The contract utilizes firm-fixed pricing to provide uninterrupted supply of this high-volume pharmaceutical across federal medical facilities. The solicitation (36E79723R0015) was posted April 6, 2023, with offers due May 5, 2023. No set-aside was applied; the procurement occurred under full and open competition. The contract leverages VA and Department of Defense Pharmaceutical Prime Vendor program protocols to streamline procurement and distribution.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36E79723D0025?
36E79723D0025 was awarded to Radha Pharmaceuticals Inc. by National Acquisition Center (Headquarters) on October 1, 2023.
How much is contract 36E79723D0025 worth?
36E79723D0025's own ceiling is $72,305,204.
Who can order from contract 36E79723D0025?
36E79723D0025 is a single award indefinite delivery contract.
Was contract 36E79723D0025 competed?
The extent of competition for 36E79723D0025 was full and open competition. The government received 9 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV